乌鸦传媒

<乌鸦传媒 class='mpt-top_cat_title'>Meeting Coverage >

ASN

<乌鸦传媒>Sparsentan Failed to Preserve Kidney Function Over Time in FSGS

However, more patients on the drug achieved partial remission of proteinuria vs irbesartan

<乌鸦传媒>Mid-Stage Win for Novel IgA Nephropathy Drug

APRIL-neutralizing antibody sibeprenlimab reduced proteinuria and stabilized eGFR

<乌鸦传媒>Saline Goes Head-to-Head With Balanced Crystalloid IV Fluids for Kidney Transplant

Researcher argued saline should be reconsidered as the standard IV fluid used

<乌鸦传媒>Mixed Results With Alerts for AKI-Related Medications in Hospital

EHR pings improved outcomes in those on PPIs, but lacked general clinical impact

<乌鸦传媒>Not So Cool After All: No CV Benefit With Lower-Temp Dialysate in Hemodialysis

Some patients in MyTEMP trial even complained cooler dialysate was "worst possible feeling"

<乌鸦传媒>Empagliflozin Protects At-Risk Patients From CKD Progression

Also cut risk for cardiovascular-related death and worsening kidney function

<乌鸦传媒>Stop RAS Inhibitors in Advanced CKD? STOP ACEi Trial Sheds Some Light

Findings do not support discontinuation to improve kidney function, researchers say

<乌鸦传媒>Avacopan Helps Vasculitis Patients With Renal Impairment Wean Off Steroids

Patients saw better eGFR recovery compared with prednisone

<乌鸦传媒>Longer Steroid Course No Better for Young Kids With Nephrotic Syndrome

Study compared 6-month course to standard 3-month therapy

<乌鸦传媒>Steroids Cut Risk for Serious Renal Events in IgA Nephropathy

Researcher says TESTING study findings support new KDIGO guidelines

<乌鸦传媒>Injectable PH1 Therapy Also Effective in Advanced CKD

Trial looked at patients with stages 3B through 5 chronic kidney disease

<乌鸦传媒>More Good News for Empagliflozin in Patients With Heart Failure

Slower renal function decline with SGLT-2 inhibitor in EMPEROR-Preserved trial

<乌鸦传媒>Investigational Oral CKD-Anemia Agent Effective, Safe

HIF-PHI daprodustat increased hemoglobin without hurting heart

<乌鸦传媒>Diuretic Bolstered Blood Pressure Control in Advanced CKD

But some safety signals did arise in 12-week trial

<乌鸦传媒>More Top Research From Kidney Week 2020

Additional studies on anemia, heart risk, and racial disparities in chronic kidney disease

<乌鸦传媒>Alternating Dual-Agent Tx Offers Better Remission in Nephropathy

Corticosteroid-cyclophosphamide bests sequential tacrolimus-rituximab in PMN

<乌鸦传媒>Finerenone Cuts Kidney, Heart Risks in CKD and T2D

Patients saw less hyperkalemia than with spironolactone but still some

<乌鸦传媒>Muscle Relaxant Tied to Severe Confusion in CKD Patients

Higher dose of baclofen associated with encephalopathy in older patients

<乌鸦传媒>New Agent Relieves Itching for Patients on Dialysis

"This is the first time anyone has shown anything that's worked"

<乌鸦传媒>SGLT-2 for Stage 3 CKD; Opioids for CKD; Kidney Transplant Discard & Disabilities

Roundup of more top abstracts from Kidney Week 2018

<乌鸦传媒>Time to Question Obesity-Based Cutoffs in Kidney Transplantation?

Study finds outcomes non-inferior to patients with BMI 35 and under

<乌鸦传媒>High-Dose Iron an Option for Maintenance Hemodialysis

High-dose noninferior to low-dose, required less erythropoiesis-stimulating agent

<乌鸦传媒>Sparsentan Cuts Proteinuria in Rare Kidney Disorder

Significant reduction in UP/C ratio with higher doses in focal segmental glomerulosclerosis patients

<乌鸦传媒>Acute Kidney Injury Linked with Higher Dementia Risk

Risk heightened even among those with full renal recovery

<乌鸦传媒>Kidney Docs Express Uncertainty About Women's Health

U.S., Canadian nephrologists especially lack confidence in contraceptive counseling

<乌鸦传媒>Home Hemodialysis Tied to Better Survival in Incident Patients

<乌鸦传媒>Kidney Outcomes Mixed Bag with Intensive Metabolic Care

Tight glucose control reduced, while intensive BP goals raised

<乌鸦传媒>Device May Ease Fistula Creation

Catheter-based, ultrasound-guided device had good long-term patency

<乌鸦传媒>Rituxan Has Promise in Idiopathic Nephropathy

B-cell targeting with rituximab seems as effective as with cyclosporine

<乌鸦传媒>CTA with IV Contrast May Mean Less Acute Kidney Injury

AKI seemed less likely than with intracoronary contrast administration

<乌鸦传媒>Boosting Water Intake Didn't Slow eGFR Decline in CKD

Water coaching did lead to better 24-hour urine volume

<乌鸦传媒>EHRs Help Identify Patients for CKD Care

Flagged at-risk patients in pragmatic trial with little added burden

<乌鸦传媒>ASN 2017: The Future of Personalized Nephrology

Tissue engineering, drug discovery challenges among highlight topics

<乌鸦传媒>Oral Treatment for T2D Tied to Renal Protection

SGLT2 inhibitor shows favorable effect on eGFR

<乌鸦传媒>Quick Steroid Withdrawal Works in Post-Transplant Diabetes

Incidence dropped from 39% to about 24%

<乌鸦传媒>Opioid Rx Linked to Higher Mortality in Dialysis Patients

Risks for hospitalization, dialysis discontinuation also higher

<乌鸦传媒>New Hospital Care Model Cut Readmissions, Boosted Satisfaction

Specialists urged to reconnect with generalist roots

<乌鸦传媒>Nephrologists at Kidney Week Blast Recertification Process

Consensus: stop making it a high-stakes exam

<乌鸦传媒>Stent Graft Keeps Vascular Access Clear

Should change practice, study leader says.

<乌鸦传媒>New Antibody Found in Membranous Nephropathy

Antibodies against THSD7A may be behind some cases.

1